2025 annual financial data
AbCellera Biologics 2025 Operating margin
AbCellera Biologics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -288.98%.
Operating income was -217,103,000 USD and net income was -146,412,000 USD.
Operating cash flow was -131,295,000 USD.
Get free AbCellera Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 75,128,000 USD
- Operating income
- -217,103,000 USD
- Net income
- -146,412,000 USD
- Operating cash flow
- -131,295,000 USD